Glycine Treatment of Prodromal Symptoms
Glycine Treatment of Prodromal Symptoms
This is an open label trial of the NMDA agonist glycine used alone for symptoms that appear to be prodromal for schizophrenia in adolescents and young adults.
Inclusion Criteria:
Exclusion Criteria: